TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

γ-Secretase modulator 11 hydrochloride 100 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 11 hydrochloride is a potent, orally active γ-secretase modulator (IC50: 0.029 μM). γ-Secretase modulator 11 hydrochloride significantly reduces brain Aβ42 levels and rescues the cognitive deficits exhibited by AD model mice. γ-Secretase modulator 11 hydrochloride has shown research potential in Alzheimer’s disease.

More Information Supplier Page

γ-Secretase modulator 12 5 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer’s disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain/plasma ratio (Kp, brain = 0.72) in mice [1].

More Information Supplier Page

γ-Secretase modulator 12 50 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer’s disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain/plasma ratio (Kp, brain = 0.72) in mice [1].

More Information Supplier Page

γ-Secretase modulator 12 100 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 12 (Compound 1a) is a selective compound that effectively reduces amyloid-β42 (Aβ42) levels with an IC50 of 0.39 μM. It is specifically designed for Alzheimer’s disease research. Notably, γ-Secretase modulator 12 exhibits a favorable brain/plasma ratio (Kp, brain = 0.72) in mice [1].

More Information Supplier Page

γ-Secretase modulator 13 5 mg  | Purity Not Available

TargetMol

gamma-secretase modulator 4 (compound 4) is a gamma-secretase modulator (GSMs) that inhibits the production of the aggregated amyloid β peptide Aβ42 (IC50: 163 nM). gamma-secretase modulator 4 can be used in the study of Alzheimer’s disease.

More Information Supplier Page

γ-Secretase modulator 13 50 mg  | Purity Not Available

TargetMol

gamma-secretase modulator 4 (compound 4) is a gamma-secretase modulator (GSMs) that inhibits the production of the aggregated amyloid β peptide Aβ42 (IC50: 163 nM). gamma-secretase modulator 4 can be used in the study of Alzheimer’s disease.

More Information Supplier Page

γ-Secretase modulator 13 100 mg  | Purity Not Available

TargetMol

gamma-secretase modulator 4 (compound 4) is a gamma-secretase modulator (GSMs) that inhibits the production of the aggregated amyloid β peptide Aβ42 (IC50: 163 nM). gamma-secretase modulator 4 can be used in the study of Alzheimer’s disease.

More Information Supplier Page

γ-Secretase modulator 4 100 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.

More Information Supplier Page

γ-Secretase modulator 4 5 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.

More Information Supplier Page

γ-Secretase modulator 4 50 mg  | Purity Not Available

TargetMol

γ-Secretase modulator 4 is a potent γ-secretase modulator, reduces the Aβ42 level with IC50s of 0.017 μM and 0.014 μM in mouse and human, respectively.

More Information Supplier Page

γ-Terpinene 500 mg  | 98.96%

TargetMol

γ-Terpinene is a monoterpene compound with high antioxidant properties suitable for oral consumption. It displays direct radical scavenging abilities and is known to be a potent antinociceptive agent.

More Information Supplier Page

γ-Terpinene 1 g  | 98.96%

TargetMol

γ-Terpinene is a monoterpene compound with high antioxidant properties suitable for oral consumption. It displays direct radical scavenging abilities and is known to be a potent antinociceptive agent.

More Information Supplier Page

γ-Tocopherol 1 mL  | 99.39%

TargetMol

(+)-γ-Tocopherol is one of the naturally occurring forms of Vitamin E. It is the most abundant Tocopherol in soybean and corn oils.

More Information Supplier Page

γ-Tocopherol 5 mg  | 99.39%

TargetMol

(+)-γ-Tocopherol is one of the naturally occurring forms of Vitamin E. It is the most abundant Tocopherol in soybean and corn oils.

More Information Supplier Page

γ-Tocotrienol 1 mL  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 1 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 2 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 5 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 10 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 25 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 50 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ-Tocotrienol 100 mg  | Purity Not Available

TargetMol

gamma-Tocotrienol is one of the four types of tocotrienol, a type of vitamin E. Itl is also a radioprotector, antioxidant. It shows antitumor and antihypertensive effects in vivo.

More Information Supplier Page

γ1-MSH 1 mg  | Purity Not Available

TargetMol

Endogenous melanocortin MC3 receptor agonist (pKi = 7.46) that displays ~ 40-fold selectivity over MC4. Increases the release of extracellular dopamine, which induces grooming and vertical activity (rearing) in rats. Exhibits hypertensive, tachycardic and short-term analgesic activity in vivo.

More Information Supplier Page

γ1-MSH TFA 5 mg  | Purity Not Available

TargetMol

γ1-MSH TFA is a melanocortin MC3 receptor agonist, with a K i of 34 nM for the rat MC3 receptor. γ1-MSH TFA displays ~40-fold selectivity over MC4 (K i =1318 nM) [1] .

More Information Supplier Page

γ1-MSH TFA 50 mg  | Purity Not Available

TargetMol

γ1-MSH TFA is a melanocortin MC3 receptor agonist, with a K i of 34 nM for the rat MC3 receptor. γ1-MSH TFA displays ~40-fold selectivity over MC4 (K i =1318 nM) [1] .

More Information Supplier Page

δ-Tocotrienol 1 mL  | 97.38%

TargetMol

δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.

More Information Supplier Page

δ-Tocotrienol 1 mg  | 97.38%

TargetMol

δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.

More Information Supplier Page

δ-Tocotrienol 5 mg  | 97.38%

TargetMol

δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.

More Information Supplier Page

δ-Tocotrienol 10 mg  | 97.38%

TargetMol

δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.

More Information Supplier Page

δ-Tocotrienol 25 mg  | 97.38%

TargetMol

δ-Tocotrienol is a potential angiogenic inhibitor. δ-Tocotrienol is also a nontoxic activator of mir-34a which can inhibit nonsmall cell lung cancer cells (NSCLC) cell proliferation, induce apoptosis and inhibit invasion, and thus offering a potential starting point for the design of novel anticancer agents.

More Information Supplier Page